4
Changes in Ownership
Organon & Co. Filed Acc 0001209191-23-023087
Chief Financial Officer gave up 2,656 shares (to pay taxes)
- Chief Financial Officer acquired 7,753 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WALSH MATTHEW M Chief Financial Officer | 2023-03-31 | Option exercise | +7,753 | 39,459 | D | ||
| WALSH MATTHEW M Chief Financial Officer | 2023-03-31 | Shares withheld for taxes | −2,656 | $23.09 | $61,327 | 36,803 | D |
| Derivatives | |||||||
| WALSH MATTHEW M Chief Financial Officer | 2023-03-31 | Option exercise · Restricted Stock Units | −7,753 | 15,507 | D | ||
| WALSH MATTHEW M Chief Financial Officer | 2023-03-31 | Grant or award · Restricted Stock Units | +36,139 | 36,139 | D | ||
| WALSH MATTHEW M Chief Financial Officer | 2023-03-31 | Grant or award · Stock Option (right to buy) | +129,770 | 129,770 | D | ||
Loading xslF345X04/doc4.xml…